August 24, 2016 7:39 AM ET

Biotechnology

Company Overview of Oncos Therapeutics Ltd

Company Overview

Oncos Therapeutics Ltd., a clinical-stage biotechnology company, develops and commercializes targeted cancer immunotherapy products. It offers ONCOS-102, an engineered human serotype 5 adenovirus optimized to induce systemic anti-tumor T cell response in cancer patients. The company also engages in the development of products using its adenovirus-based cancer immunotherapy platform for the treatment of various cancer types, including soft tissue sarcoma, ovarian cancer, and mesothelioma. Oncos Therapeutics Ltd. was founded in 2009 and is based in Helsinki, Finland. As of July 2, 2015, Oncos Therapeutics Ltd operates as a subsidiary of Targovax AS.

Saukonpaadenranta 2

Helsinki,  00180

Finland

Founded in 2009

Phone:

358 4073 00445

Fax:

358 9856 57321

Key Executives for Oncos Therapeutics Ltd

Chief Executive Officer and President
Co-Founder and Chief Operating Officer
Head of Clinical Science
Vice President Strategy Via Lifeline Ventures
Compensation as of Fiscal Year 2016.

Oncos Therapeutics Ltd Key Developments

Oncos Therapeutics Ltd. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015

Oncos Therapeutics Ltd. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Presentation Date & Speakers: Mar-03-2015, Frans Gustaf Wuite, Chief Executive Officer and President.

Oncos Therapeutics Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015

Oncos Therapeutics Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Oncos Therapeutics Ltd. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 09:10 AM

Oncos Therapeutics Ltd. Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 09:10 AM. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland.

Similar Private Companies By Industry

Company Name Region
Arctic Diagnostics Oy Europe
Aurealis Oy Europe
Biovian Oy Europe
Bioxid Ltd Oy Europe
Blueprint Genetics Oy Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncos Therapeutics Ltd, please visit www.oncos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.